SubArachnoid Hemorrhage HEadache Treated by Lumbar Puncture
SAH-HELP
2 other identifiers
interventional
74
1 country
1
Brief Summary
Headache control is one of the major challenges in patients who suffered an acute aneurysmal subarachnoid hemorrhage (aSAH). Headache affects 90% of the patient and is resistant to the major pain medication. It results from the increased intracranial pressure and the inflammation caused by the accumulation of arterial blood in the subarachnoid space. Hemorrhagic cerebrospinal fluid (CSF) removal by a lumbar puncture (LP), is well tolerated, reduces intracranial pressure and accelerates the clearance of the blood products from CSF. Nonetheless it has never been tested in a randomized trial. The investigators aim to compare in patients who experienced a low grade aSAH, the variation of headache intensity after CSF removal by LP vs. Sham LP in addition to predefined analgesic protocol management.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2018
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 19, 2018
CompletedFirst Posted
Study publicly available on registry
November 27, 2018
CompletedStudy Start
First participant enrolled
November 28, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2022
CompletedMay 29, 2026
May 1, 2026
4 years
November 19, 2018
May 28, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Difference of headache mean intensity variation measured after a lumbar puncture or a sham LP.
The mean intensity will be assessed using the verbal rating scales (VRS). It is a scale administered by the medical team, which brings together the score given by the patient between 0 and 10 (0 = absence of pain; 10 = maximum of conceivable pain)Headache mean intensity variation will be calculated by the difference between these scores evaluated 24 hours before and the 24 hours after the procedure.
24 hours after the inclusion
Secondary Outcomes (7)
Difference of variation in the mean intensity of headache
48 hours
Difference of maximal headache intensity
48 hours
Kinetic of headache intensity
7 days
Difference of responding patients
7 days
Occurrence of a clinical deterioration
1 day
- +2 more secondary outcomes
Study Arms (2)
Lumbar puncture
EXPERIMENTALLumbar puncture in addition to a predefined analgesic protocol Patients will be randomized between the 3rd and 5th days following aneurismal rupture.
Sham lumbar puncture
ACTIVE COMPARATORSham lumbar puncture in addition to a predefined analgesic protocol Patients will be randomized between the 3rd and 5th days following aneurismal rupture.
Interventions
Patient will be managed according to the current international recommendations in the Toulouse acute stroke center. In the absence of clear recommendation in the literature headache will be treated according to our local predefined analgesic protocol: paracetamol 1g/6 h, and if the numerical scale ≥ 4 : continuous intravenous morphine starting at 1mg/h and increased per 0.5 mg/h every hour if numerical scale remains ≥ 4. Lumbar puncture will be performed between day 3 and day 5 after subarachnoid hemorrhage onset by an independent scientist from our clinical investigator center. 30-mL CSF will be removed by LP. Sham LP consisting in superficial skin puncture by a subcutaneous needle (27 gauge needle) during the usual procedure will be performed at the same time point.
Eligibility Criteria
You may qualify if:
- Age \>18 years
- Low grade subarachnoid hemorrhage (WFNS score between 1 and 3)
- Aneurysmal rupture ≤ 5 days
- Ruptured aneurysm secured by coiling since at least 48 h
- Headache with a mean numeric verbal scale ≥ 4/10 during the last 24 hours
- No contraindication for lumbar puncture
- Affiliation to french social security
- Person able to express her consent and to assess own headache intensity
You may not qualify if:
- Minor,
- Pregnancy, breastfeeding
- Subarachnoid hemorrhage without aneurysm
- Ruptured aneurysm not secured
- High grade (WFNS 4 and 5) subarachnoid hemorrhage
- Efficient anticoagulation
- External ventricular drain placed before randomisation
- People under legal protection
- Participation to another research study with an ongoing disqualification period
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital Toulouse
Toulouse, 31059, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lionel Calvière, MD
University Hospital, Toulouse
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Masking Details
- This procedure is to be able to easily randomize half of the patients into a "sham" LP arm passed by independent practitioners of the investigators in charge of the patient, which allows a good double-blind study.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 19, 2018
First Posted
November 27, 2018
Study Start
November 28, 2018
Primary Completion
December 1, 2022
Study Completion
December 1, 2022
Last Updated
May 29, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will not share